Syntrix Biosystems, Inc.'s Costs Claimed Under the Recovery Act for National Institutes of Health Grant 3R44CA094612-05S2 Were Unallowable
Of the $200,000 of costs that Syntrix Biosystems, Inc., claimed against the Recovery Act grant, the entire amount was unallowable.
Filed under: National Institutes of Health